Healthcare - Biotechnology - NASDAQ - US
$ 20.43
-7.56 %
$ 306 M
Market Cap
-4.3
P/E
Price Target
Average
119.45%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
4.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Jasper Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for JSPR of $44.8 , with forecasts ranging from a low of $3 to a high of $65 .
JSPR Lowest Price Target
Wall Street Target
3 USD
-85.32%
JSPR Average Price Target
Wall Street Target
44.8 USD
119.45%
JSPR Highest Price Target
Wall Street Target
65 USD
218.16%
REVENUE FORECAST
Revenue Forecast Chart JSPR
EBIT FORECAST
EBIT Forecast Chart JSPR
NET INCOME FORECAST
Net Income Chart JSPR